Skip to content

Screener

Eligibility screening

A Study of Neladalkib (NVL-655)

Sponsored by Nuvalent Inc.Study detailsClinicalTrials.gov

21 US sites in CA, CO, DC, FL +13

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.